7:50 am Chair’s Opening Remarks
An Overview of Progress Towards Achieving Successful Antigen Specific Therapeutics
8:00 am Antigen-Specific Immunotherapy Approaches for the Treatment of Autoimmune Diseases
8:30 am Translating Innovative Science to Therapies that Establish Immune Tolerance – One Pharma’s Perspective
Clinical Readouts & Translation: What can we Learn from the Clinic? Implications for Designing Clinical Trials
9:00 am Antigen-Specific Immunotherapy for Treatment of Autoimmune Diseases
9:30 am From Bench to Bedside: Pre-Clinical & Clinical Results of Tolerogenic Therapy of Celiac Disease using Gliadin-Encapsulating PLG Nanoparticles
10:00 am Speed Networking
Synopsis
This session is the ideal opportunity to get face-to-face time with many of the brightest minds working in the Antigen-Specific Immune Tolerance field and establish meaningful business relationships to pursue for the rest of the conference.